The collagen-modifying enzyme GLT25D1 is a prognostic indicator related to immunosuppression and malignant phenotypes in hepatocellular carcinoma
Abstract Background The collagen β (1-O) glycosyltransferase 25 domain 1 (GLT25D1), a crucial collagen-modifying enzyme (CME), plays a pivotal role in multiple pathophysiological processes. However, its prognostic and biological roles in hepatocellular carcinoma (HCC) have not been reported. Methods...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2025-03-01
|
| Col·lecció: | Cancer Cell International |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s12935-025-03715-z |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
